Policies / Policy record
H.R. 3537 — Accelerating Access to Critical Therapies for ALS Act
Federal · SIGNED / ENACTED
Purpose
Established federal grant and coordination programs intended to support ALS and other rare neurodegenerative disease research, development, and access to investigational therapies.
Official summary
Congress.gov describes grant programs for research using expanded-access data, drug development, a public-private partnership, and an FDA action plan for rare neurodegenerative diseases.
ALS and gene-carrier relevance
This record directly references ALS research, access, benefits, or related infrastructure. The official source controls the legal scope.
Policy scope and insurance types
- Policy scope
- Not stated
- Genetic policy scope
- Not stated
- Insurance types affected
- Not stated
- Policy type
- Bill
- Record type
- Current Bill
- Time status
- Current
- Verification
- Verified
- Discovered from
- Official Legislature
- Status detail
- Not stated
- Companion bills
- Not stated
- Derived from bill
- Not stated
- Codified as
- Not stated
Jurisdiction and session
- Jurisdiction
- Federal
- Session
- 117th Congress (2021–2022)
- Topics
- ALS research funding, clinical-trial access, Expanded Access, drug approval/access, research infrastructure
- Bill / act number
- H.R. 3537 · Public Law 117-79
- Introduced
- 05-25-2021
- Last action
- 12-23-2021
- Passed House / Assembly
- 12-08-2021
- Passed Senate
- 12-16-2021
- Governor action
- Not stated
- Approved / enacted
- 12-23-2021
- Effective
- 12-23-2021
- Vetoed
- Not stated
Sponsors, cosponsors, and committees
Sponsors
- Rep. Mike Quigley
Cosponsors
- 331 cosponsors listed on the official record
Committees
- House Committee on Energy and Commerce
Legislative support and votes
Vote history
- House: passed 423–3 on 12-08-2021
- Senate: passed without amendment by voice vote on 12-16-2021
Verified organization support
No verified organization support recorded in this policy snapshot.
Verified opposition
No verified organization opposition recorded in this policy snapshot.
Historical timeline
Introduced in the House.
Passed the House, 423–3.
Passed the Senate without amendment by voice vote.
Became Public Law 117-79.
Official text and source links
External links open in a new tab. Exact official sources are used for verified records.
Last verified: 09-30-2026
Last verified source: Open verification source ↗
Policy records are educational and neutral. A policy record is not legal, insurance, benefits, or medical advice. Confirm current text, status, effective dates, and eligibility with the official source and a qualified professional.